MOH will only allowed approved cancer treatment drugs to be claimable under the basic and integrated shield plan from 2023. This may means that patients may missed out on cost effective drugs but not on MOH list due to the cost. This imply that it had to come out of our pocket. This will affect average Singaporeans like us but not the affluent people.
This will allowed us to have limited access to cost effective drugs on the market. The main primary reason is the cost as we will not be able to afford it. Thus, we will have to depend on drugs on the MOH approved list. It may not be the best effective drugs but is cost efficient to the government. It may not sound reasonable to the average residents in Singapore.
Please stay healthy if you want to have a good and sustainable life. Nothing is free here and everything comes with a cost.